» Articles » PMID: 25896009

Inflammatory Stress Exacerbates Lipid Accumulation and Podocyte Injuries in Diabetic Nephropathy

Overview
Journal Acta Diabetol
Specialty Endocrinology
Date 2015 Apr 22
PMID 25896009
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Diabetic nephropathy (DN) is a chronic inflammatory disease that is accompanied by different degrees of lipid disorders. The present study was conducted to determine whether inflammatory stress exacerbates lipid accumulation in podocytes and to investigate its underlying mechanisms in DN using in vitro and in vivo studies.

Methods: We used IL-1β stimulation in podocytes in vitro and casein injections in db/db mice in vivo to induce inflammatory stress. The plasma levels of serum inflammatory cytokines were determined using an enzyme-linked immunosorbent assay. The renal pathology was evaluated using pathological staining and electron microscopy. Intracellular lipid accumulation was evaluated by Oil Red O staining and a cholesterol quantitative assay. The gene and protein expression levels of extracellular matrix proteins, biomarkers of podocyte injury, and molecules involved in the LDLr pathway were evaluated using immunofluorescence staining, real-time PCR, and western blot analysis.

Results: Increased plasma levels of inflammatory cytokines in the casein-injected db/db mice indicated a successful induction of the inflamed DN model. The kidney morphological changes, podocyte injury, and epithelial mesenchymal transition (EMT) were more significant in casein-injected db/db mice. Moreover, inflammation increased the lipid droplet accumulation in the kidneys of db/db mice, which resulted from the increased protein expression levels of LDLr, sterol regulatory element-binding protein (SREBP) cleavage-activating protein (SCAP), and SREBP-2 in the kidneys of db/db mice. The in vitro studies further demonstrated that inflammation increased the lipid accumulation in the podocytes and induced podocyte EMT, which were correlated with inflammation-mediated increases in the expression levels of LDLr, SCAP, and SREBP-2, and increased translocation of the SCAP/SREBP-2 complex from the endoplasmic reticulum to the Golgi in the podocytes.

Conclusion: Inflammation induced lipid accumulation and the EMT of podocytes through the dysregulation of the LDLr pathway, which contributed to podocyte injury and accelerated the progression of DN.

Citing Articles

Lipid homeostasis in diabetic kidney disease.

Wang Y, Liu T, Wu Y, Wang L, Ding S, Hou B Int J Biol Sci. 2024; 20(10):3710-3724.

PMID: 39113692 PMC: 11302873. DOI: 10.7150/ijbs.95216.


N1F(Improved-Nephropathy 1 Formula) Ameliorates Renal Interstitial Fibrosis via Inhibiting Extracellular Matrix Deposition and Regulating the FGF23/P38MAPK/Wnt Pathway.

Yu W, Zeng C, Wang C, Jia S, Liu C, Zeng Y Cell Biochem Biophys. 2024; 82(2):927-943.

PMID: 38722471 DOI: 10.1007/s12013-024-01244-6.


Unraveling the Crosstalk between Lipids and NADPH Oxidases in Diabetic Kidney Disease.

Njeim R, Alkhansa S, Fornoni A Pharmaceutics. 2023; 15(5).

PMID: 37242602 PMC: 10222020. DOI: 10.3390/pharmaceutics15051360.


Inhibition of EZH2 mitigates peritoneal fibrosis and lipid precipitation in peritoneal mesothelial cells mediated by klotho.

Wang Q, Sun J, Wang R, Sun J Ren Fail. 2023; 45(1):2149411.

PMID: 36724065 PMC: 9897791. DOI: 10.1080/0886022X.2022.2149411.


A novel fusion protein consisting of anti-ANGPTL3 antibody and interleukin-22 ameliorates diabetic nephropathy in mice.

Ma Q, Hu X, Liu F, Cao Z, Han L, Zhou K Front Immunol. 2022; 13:1011442.

PMID: 36544775 PMC: 9760875. DOI: 10.3389/fimmu.2022.1011442.